Eli Lilly Cuts Obesity Drug Cost to $449 with New Plan

Eli Lilly just made its weight loss drug Zepbound more affordable for millions of workers by letting employers chip in on the cost.

Instead of charging insurance prices, they're offering it at $449 a month with flexible employer subsidies.